Chennai Meenakshi Multispeciality Hospital Ltd vs Dr Agarwals Health Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 33.15 as of 30 Oct 15:30 . The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Dr Agarwals Health Care Ltd changed from 169.3 on March 2025 to 96.7 on March 2026 . This represents a CAGR of -24.42% over 2 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Dr Agarwals Health Care Ltd changed from ₹ 14116 crore on March 2025 to ₹ 12867 crore on March 2026 . This represents a CAGR of -4.53% over 2 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Dr Agarwals Health Care Ltd for the Jun '26 is ₹ 620.43 crore as compare to the Mar '26 revenue of ₹ 578.02 crore. This represent the growth of 7.34% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Dr Agarwals Health Care Ltd for the Jun '26 is ₹ 176.82 crore as compare to the Mar '26 ebitda of ₹ 175.38 crore. This represent the growth of 0.82% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Dr Agarwals Health Care Ltd changed from ₹ 18.22 crore to ₹ 55.02 crore over 9 quarters. This represents a CAGR of 63.43% The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Dr Agarwals Health Care Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology. The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.

About Dr Agarwals Health Care Ltd

Dr Agarwal's Health Care Limited was incorporated as Dr. Agarwal's Health Care Limited' pursuant to Certificate of Incorporation dated April 19, 2010, issued by the Registrar of Companies, Tamil Nadu at Chennai and commenced operations pursuant to Certificate for Commencement of Business dated May 29, 2010, issued by the RoC. The Company provide eye care services and products, covering cataract surgeries, refractive treatments and other surgeries; and services such as consultations, clinical investigations and diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products.
It offer surgeries for multiple eye ailments, including cataract, corneal, retinal, and refractive, and other surgeries.
It provide other treatments, including glaucoma treatments, squint treatments, and oculoplasty surgeries, among others.

FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and Dr Agarwals Health Care Ltd

Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Dr Agarwals Health Care Ltd?

Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 24 Cr while Market cap of Dr Agarwals Health Care Ltd is 16,116 Cr

What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Dr Agarwals Health Care Ltd?

The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Dr Agarwals Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Dr Agarwals Health Care Ltd?

As of November 1, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹33.15. On the other hand, Dr Agarwals Health Care Ltd stock price is INR ₹508.35.

How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Dr Agarwals Health Care Ltd compare?

To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Dr Agarwals Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.